Barbara-Jean Bormann-Kennedy
Director/Board Member presso BIOLINERX LTD.
Patrimonio netto: 176 813 $ in data 29/02/2024
Profilo
Barbara-Jean Bormann-Kennedy is VP-Translational Science & Network Alliances at The Jackson Laboratory and on the board of 5 other companies.
In the past she held the position of President, Chief Executive Officer & Director at BetterLife Pharma, Inc., Chief Executive Officer & Director at Supportive Therapeutics, Head-Strategic Alliances at Pfizer Inc., Consultant at Paperboy Ventures LLC, Chief Executive Officer & Director at Harbour Antibodies BV and Senior VP-Business Development & Licensing at Boehringer Ingelheim Pharmaceuticals, Inc.
Dr. Bormann-Kennedy received an undergraduate degree from Fairfield University and a doctorate from the University of Connecticut Health Center.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
07/06/2023 | 57 500 ( 0.04% ) | 176 813 $ | 29/02/2024 | |
BIOLINERX LTD.
-.--% | 21/03/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Posizioni attive di Barbara-Jean Bormann-Kennedy
Società | Posizione | Inizio |
---|---|---|
BIOLINERX LTD. | Director/Board Member | 19/08/2013 |
XERIS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 05/10/2021 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Institute For Pediatric Innovation, Inc.
Institute For Pediatric Innovation, Inc. Medical/Nursing ServicesHealth Services Institute For Pediatric Innovation, Inc. provides healthcare services. The non-profit company is based in Cambridge, MA. | Director/Board Member | - |
Rincon Pharmaceuticals, Inc.
Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Director/Board Member | - |
The Jackson Laboratory
The Jackson Laboratory BiotechnologyHealth Technology The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME. | Corporate Officer/Principal | 01/08/2017 |
Precedenti posizioni note di Barbara-Jean Bormann-Kennedy
Società | Posizione | Fine |
---|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Director/Board Member | 05/10/2021 |
Supportive Therapeutics | Chief Executive Officer | 01/07/2017 |
Harbour Antibodies BV
Harbour Antibodies BV Medical/Nursing ServicesHealth Services Harbour Antibodies BV engages in the production of antibodies and VH domains for therapy. The firm develops two types of human immunoglobulin gene transgenic mice such as mice that generate conventional tetrameric antibodies comprising two heavy and two light immunoglobulin chains (H2L2); and alternatively, mice that generate heavy chain only antibodies comprising two immunoglobulin heavy chains with no light chains (HCAbs). The company was founded by Frank Grosveld in 2006 and is headquartered in Rotterdam, the Netherlands. | Chief Executive Officer | 01/01/2017 |
░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Barbara-Jean Bormann-Kennedy
Fairfield University | Undergraduate Degree |
University of Connecticut Health Center | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
PFIZER, INC. | Health Technology |
BETTERLIFE PHARMA INC. | Health Technology |
BIOLINERX LTD. | Health Technology |
XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
Aziende private | 9 |
---|---|
Rincon Pharmaceuticals, Inc.
Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
The Jackson Laboratory
The Jackson Laboratory BiotechnologyHealth Technology The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Paperboy Ventures LLC
Paperboy Ventures LLC Investment ManagersFinance Founded in 2003 by Allen Andersson, Paperboy Ventures LLC is a venture capital firm located in Washington, DC. | Finance |
Harbour Antibodies BV
Harbour Antibodies BV Medical/Nursing ServicesHealth Services Harbour Antibodies BV engages in the production of antibodies and VH domains for therapy. The firm develops two types of human immunoglobulin gene transgenic mice such as mice that generate conventional tetrameric antibodies comprising two heavy and two light immunoglobulin chains (H2L2); and alternatively, mice that generate heavy chain only antibodies comprising two immunoglobulin heavy chains with no light chains (HCAbs). The company was founded by Frank Grosveld in 2006 and is headquartered in Rotterdam, the Netherlands. | Health Services |
Institute For Pediatric Innovation, Inc.
Institute For Pediatric Innovation, Inc. Medical/Nursing ServicesHealth Services Institute For Pediatric Innovation, Inc. provides healthcare services. The non-profit company is based in Cambridge, MA. | Health Services |
Supportive Therapeutics |